The clinical and regulatory basis of TherapeuticAI®

TherapeuticAI® is the clinical-decision layer that turns assessment signal into structured, clinician-governed therapy planning — built on evidence, bounded by regulation.

In short

TherapeuticAI® is the therapy-intelligence component within the Pinnacle Blooms Network platform that supports clinicians in translating structured assessment data into individualised, goal-oriented intervention plans across speech, occupational, behavioural and developmental therapy. Its clinical basis rests on established developmental-science frameworks and a corpus of 2.5 billion+ data points drawn from 25 million+ therapy sessions; its regulatory posture is that of a clinician-support tool operating outside the regulated SaMD boundary — it informs, but does not diagnose or autonomously direct care. The clinical AbilityScore® that anchors any plan is a separate, clinician-administered structured assessment, and diagnosis always remains a human clinical act.

The clinical basis

TherapeuticAI® is grounded in the same evidence base that governs paediatric developmental therapy internationally: WHO developmental and nurturing-care frameworks, AAP and ASHA practice guidance, and EACD developmental standards. It does not generate novel clinical claims; it operationalises consensus practice by pattern-matching a child's structured profile against anonymised, validated session data to surface goal hierarchies, suggested intervention targets and progress-tracking parameters for clinician review. The intelligence is corpus-informed — 12 validated studies and a deployment footprint of 700+ therapists, 70+ centres across 4 states and 4.95 lakh+ families contribute to its continuous refinement — but every output is advisory and clinician-gated. No therapeutic decision is executed without a qualified clinician's judgement.

The regulatory basis

The network's regulated diagnostic component holds CDSCO Class B SaMD status. TherapeuticAI®, by contrast, is positioned outside the SaMD boundary: it functions as a clinical workflow and decision-support aid that proposes therapy-planning options for a clinician to accept, modify or reject, rather than producing a regulated diagnostic or treatment output autonomously. This intended-use framing — informing rather than directing care — is what keeps it outside the medical-device classification, while the diagnostic engine that does carry device obligations is separately governed. The platform is protected by 16+ WIPO PCT patents spanning these methods. For peer partners, the practical implication is clear: TherapeuticAI® augments clinical reasoning and standardises planning quality; it does not replace clinical accountability.

The Pinnacle way

A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care — never from an app, a form, or an algorithm alone. Clinicians can review how the assessment layer is administered and governed via the AbilityScore®, see how planning supports delivery in speech therapy and allied services, and explore partnership and platform access through our [main network](/).

Trusted sources

WHO frameworks on developmental health and nurturing care; ASHA and AAP guidance on evidence-based paediatric therapy practice; EACD developmental standards; and India's CDSCO medical-device classification framework distinguishing software as a medical device from clinical decision-support tools.

Next step — Clinicians and institutions seeking to evaluate TherapeuticAI® for integrated, evidence-aligned therapy planning can request a partnership briefing and clinical-governance walkthrough.

This is general information, not a diagnosis — a clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.